AVERAGE LINKAGE CLUSTERING METHOD AND MOLECULAR DOCKING STUDY ON DATE PALM (PHOENIX DACTYLIFERA L.) AS POTENTIAL ANTI-ANEMIA AGENT
Abstract
Anemia, characterized by blood hemoglobin (Hb) levels below the World Health Organization's (WHO) normal limit, remains a significant health concern. Date fruit (Phoenix dactylifera L.) stands out as an herbal plant boasting the highest iron content at 13.7 mg, suggesting its potential as an anti-anemia agent. This study aimed to explore the anti-anemia potential of active compounds in date fruit using average linkage clustering and validated using molecular docking. Compounds from dates were gathered via GC-MS analysis and online databases, totaling 145 compounds—50 from GC-MS and 95 from Knapsack and Dr. Duke databases. Additionally, 5 lead compounds served as positive controls for comparison. SwissADME online servers assessed the compounds' properties, serving as materials for the clustering method. The average linkage clustering method was employed, yielding an excellent dendrogram with a cophenetic correlation of 0.711. Notably, a total of 17 date fruit compounds are in the same cluster as the lead compounds. Molecular docking revealed 4 date palm fruit-derived compounds as potential PHD enzyme inhibitors, promising for anemia treatment. In conclusion, the average linkage clustering method and validation using molecular docking approaches highlight date fruit's potential as an alternative anemia treatment, showcasing the significance of interdisciplinary methodologies in drug discovery.
Downloads
References
R. J. Derman and A. Patted, “Overview of Iron Deficiency and Iron Deficiency Anemia in Women and Girls of Reproductive Age,” International Journal of Gynecology and Obstetrics, vol. 162, no. S2, pp. 78–82, Aug. 2023, doi: 10.1002/ijgo.14950.
S. Y. Hess, A. Owais, M. E. D. Jefferds, M. F. Young, A. Cahill, and L. M. Rogers, “Accelerating Action to Reduce Anemia: Review of Causes and Risk Factors and Related Data Needs,” Annals of the New York Academy of Sciences, vol. 1523, no. 1. John Wiley and Sons Inc, pp. 11–23, May 01, 2023. doi: 10.1111/nyas.14985.
R. I. Kemenkes, “Laporan hasil riset kesehatan dasar (Riskesdas) Indonesia tahun 2018,” Riset Kesehatan Dasar, vol. 2018, pp. 182–183, 2018.
C. M. Chaparro and P. S. Suchdev, “Anemia Epidemiology, Pathophysiology, and Etiology in Low‐and Middle‐Income Countries,” Ann N Y Acad Sci, vol. 1450, no. 1, pp. 15–31, 2019.
Institute for Health Metrics and Evaluation, “The Global Burden of Disease.”
T. W. Wu and F. P. Tsai, “Comparison of the Therapeutic Effects and Side Effects of Oral Iron Supplements in Iron Deficiency Anemia,” Drug Res, vol. 66, no. 5, pp. 257–261, May 2016, doi: 10.1055/s-0035-1569326.
K. J. Kumar, N. Asha, D. S. Murthy, M. S. Sujatha, and V. G. Manjunath, “Maternal Anemia in Various Trimesters and Its Effect on Newborn Weight and Maturity: An Observational Study,” Int J Prev Med, vol. 4, no. 2, p. 193, 2013.
D. Moretti et al., “Oral Iron Supplements Increase Hepcidin and Decrease Iron Absorption from Daily or Twice-Daily Doses in Iron-Depleted Young Women,” The Journal of the American Society of Hematology Blood, vol. 126, no. 17, pp. 1981–1989, 2015.
Z. Tolkien, L. Stecher, A. P. Mander, D. I. A. Pereira, and J. J. Powell, “Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis,” PLoS One, vol. 10, no. 2, p. 117383, 2015.
N. U. Stoffel, H. K. von Siebenthal, D. Moretti, and M. B. Zimmermann, “Oral Iron Supplementation in Iron-Deficient Women: How Much and How Often?,” Mol Aspects Med, vol. 75, Oct. 2020, doi: 10.1016/j.mam.2020.100865.
R. Husnah, S. As’ad, W. Sinrang, N. Usman, M. Ahmad, and H. Hidayanty, “Addition Of Sukkari Dates (Phoenix Dactylifera L) And Fe Supplementation In Increasing Ferritin Levels To Young Women With Anemia,” Annals of R.S.C.B., vol. 25, no. 4, pp. 17377–17389, 2021, [Online]. Available: http://annalsofrscb.ro
F. D. Prieto-Martínez, M. Arciniega, and J. L. Medina-Franco, “Molecular docking: current advances and challenges,” TIP. Revista especializada en ciencias químico-biológicas, vol. 21, 2018.
A. Venkatesan, M. Rambabu, S. Jayanthi, and J. Febin Prabhu Dass, “Pharmacophore Feature Prediction and Molecular Docking Approach to Identify Novel Anti-HCV Protease Inhibitors,” J Cell Biochem, vol. 119, no. 1, pp. 960–966, Jan. 2018, doi: 10.1002/jcb.26262.
P. Govender and V. Sivakumar, “Application of K-Means and Hierarchical Clustering Techniques for Analysis of Air Pollution: A Review (1980–2019),” Atmospheric Pollution Research, vol. 11, no. 1. Elsevier B.V., pp. 40–56, Jan. 01, 2020. doi: 10.1016/j.apr.2019.09.009.
J. Lu et al., “Identification of new candidate drugs for lung cancer using chemical–chemical interactions, chemical–protein interactions and a K-means clustering algorithm,” J Biomol Struct Dyn, vol. 34, no. 4, pp. 906–917, 2016.
C. Anneke and C. Andreas, “Application of The Hierarchical Cluster Method in Analyzing The Characteristics of Parenting Patterns for Early Childhood in Indonesia,” International Journal of Academic and Applied Research (IJAAR) , vol. 6, no. 12, pp. 180–186, 2022.
A. L. Yusniyanti, F. Virgantari, and Y. E. Faridhan, “Comparison of Average Linkage and K-Means Methods in Clustering Indonesia’s Provinces Based on Welfare Indicators,” in Journal of Physics: Conference Series, IOP Publishing, 2021, p. 012071.
Y. Reinaldi, N. Ulinnuha, and M. Hafiyusholeh, “Comparison of Single Linkage, Complete Linkage, and Average Linkage Methods on Community Welfare Analysis in Cities and Regencies in East Java,” Jurnal Matematika, Statistika dan Komputasi, vol. 18, no. 1, pp. 130–140, 2021.
R. Jakhar, M. Dangi, A. Khichi, and A. K. Chhillar, “Relevance of Molecular Docking Studies in Drug Designing,” Curr Bioinform, vol. 15, no. 4, pp. 270–278, 2020.
I. M. Fitriani, D. E. Ratnawati, and S. Anam, “Klasifikasi Senyawa Kimia dengan Notasi Simplified Molecular Input Line Entry System (SMILES) menggunakan Metode Extreme Learning Machine (ELM),” Jurnal Pengembangan Teknologi Informasi dan Ilmu Komputer, vol. 3, no. 5, pp. 4516–4524, 2019.
J.-K. Lee et al., “Alleviation of Ascorbic Acid-Induced Gastric High Acidity by Calcium Ascorbate In Vitro and In Vivo,” The Korean Journal of Physiology & Pharmacology, vol. 22, no. 1, pp. 35–42, 2018.
N. Abbaspour, R. Hurrell, and R. Kelishadi, “Review on Iron and Its Importance For Human Health,” J Res Med Sci, vol. 19, no. 2, p. 164, 2014.
A. I. Khan et al., “Efficacy and Safety of Ferric Derisomaltose for Treatment of Anemia in Chronic Kidney Disease Patients: A Systematic Review,” Blood, p. 138, 2021.
L. P. Węgier et al., “Ferrous Sulfate Oral Solution in Young Children with Iron Deficiency Anemia: An Open‐Label Trial of Efficacy, Safety, and Acceptability,” Pediatrics International, vol. 62, no. 7, pp. 820–827, 2020.
D. C. Ford et al., “Ferumoxytol Versus Placebo in Iron Deficiency Anemia: Efficacy, Safety, And Quality Of Life in Patients with Gastrointestinal Disorders,” Clin Exp Gastroenterol, vol. 9, pp. 151–162, 2016.
E. F. Pettersen et al., “UCSF Chimera—A visualization system for exploratory research and analysis,” J Comput Chem, vol. 25, no. 13, pp. 1605–1612, Oct. 2004, doi: 10.1002/jcc.20084.
G. M. Morris et al., “AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility,” J Comput Chem, vol. 30, no. 16, pp. 2785–2791, Dec. 2009, doi: 10.1002/jcc.21256.
G. M. Morris et al., “Automated Docking Using a Lamarckian Genetic Algorithm and an Empirical Binding Free Energy Function,” J Comput Chem, vol. 19, no. 14, 1998.
M. J. Koury, “Can Prolyl Hydroxylase Inhibition Treat EPO-Deficient Anemia of Renal Failure With Fewer Vascular Complications Than EPO Itself?,” The Hematologist, vol. 12, no. 2, 2015.
Copyright (c) 2024 Siswanto Siswanto, Herlina Rasyid, Nur Aliah Ramadhani, Nadia Nazwadiah Caesar, Nurtiti Sunusi, Zaraswati Dwyana Zainuddin
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this Journal agree to the following terms:
- Author retain copyright and grant the journal right of first publication with the work simultaneously licensed under a creative commons attribution license that allow others to share the work within an acknowledgement of the work’s authorship and initial publication of this journal.
- Authors are able to enter into separate, additional contractual arrangement for the non-exclusive distribution of the journal’s published version of the work (e.g. acknowledgement of its initial publication in this journal).
- Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published works.
1.gif)
